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21 Abstract: Prebiotics may improve ageing-related dysbiosis. Milk is a source of nutrients 
2 including oligosaccharides whose prebiotic potential remains largely unexplored. We used a 
3 murine model to explore the effect of milk products on high diversity and lower diversity 
4 faecal microbiota from healthy and frail elderly subjects, respectively. Mice were treated with 
5 antibiotics and subsequently “humanised” with human faecal microbiota. The mice received 
6 lactose-free or whole milk, glycomacropeptide, or soy protein (control) supplemented diets 
7 for one month. The faecal microbiota was analysed by 16S rRNA gene amplicon sequencing. 
8 Lactose-free milk diet was as efficient as the control diet in retaining faecal microbiota 
9 diversity in mice. Both milk diets had a significant effect on the relative abundance of health-
10 relevant taxa (e.g. Ruminococcaceae, Lachnospiraceae). The glycomacropeptide prebiotic 
11 activity previously observed in vitro was not replicated in vivo. However, these data indicate 
12 the novel prebiotic potential of bovine milk for human nutrition.
13 Key words: ageing, faecal microbiota, “humanised” mice, milk, lactose free milk, 
14 glycomacropeptide, soy protein, prebiotic potential
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315 Introduction
16 During the last decade in particular, the bacterial component of the human gut microbiota has 
17 been intensively studied providing a more comprehensive understanding of the compositional 
18 and functional profile of the gut microbiota in health and disease 1. Habitual diet, and to a 
19 lesser extent host genetics, are two factors that shape the gut microbiota 2-4. The term 
20 dysbiosis refers to shifts in the composition, function and phylogenetic diversity of the gut 
21 microbiota of non-healthy individuals in comparison to healthy controls 1. Metabolic disease, 
22 functional gastrointestinal (GIT) disorders and cognitive disorders have been linked to 
23 dysbiosis 1. 
24 The low-grade chronic inflammation that characterises older age reflects the decline of 
25 immune system fitness to respond to stressors, a phenomenon called inflammaging 5. Altered 
26 intestinal permeability and dysbiotic gut microbiota are potential inflammaging drivers 5-7. 
27 Gut microbiota dysbiosis can be further fuelled by an inflamed GIT environment 8. For 
28 prevention and treatment of dysbiosis and associated conditions, therapeutic interventions 
29 based on probiotics, prebiotics or faecal microbiota transplants (FMT) are being developed 1. 
30 Bovine milk combines many nutrients including high quality protein, calcium, potassium and 
31 magnesium, vitamins such as vitamin D, fatty acids such as conjugated linoleic acid, complex 
32 sialylated oligosaccharides and glycoproteins 9, 10. There is accumulating data pointing 
33 towards certain health benefits of milk and dairy consumption 9, 11,-12. Importantly, milk 
34 consumption may contribute to muscle and bone density maintenance in older consumers 13, 
35 14. Despite the potential health benefits, studies have shown that elderly people often fail to 
36 meet current recommendations for daily dairy consumption partly due to misconceptions 
37 about lactose mal-absorption and dairy fat content 15, 16.
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438 The effect of milk ingestion on the gut microbiota has not been extensively studied. A few 
39 recent studies have focused on the potential prebiotic effect of milk oligosaccharides on the 
40 gut microbiota. Using animal models “humanised” with infant gut microbiota, Charbonneau 
41 et al. 17 showed that sialylated bovine milk oligosaccharides (BMO) promoted weight gain 
42 associated with Bacteroides fragilis and Escherichia coli responsiveness to BMOs under 
43 malnutrition conditions. Karav et al. 18 showed that BMO released from glycoproteins could 
44 mimic human milk oligosaccharide (HMO) selectivity for Bifidobacterium strains in the 
45 infant gut microbiota. Boudry et al. 19 observed that a BMO-supplemented diet enhanced gut 
46 barrier function, increased caecal and colonic microbiota diversity and Lactobacillus relative 
47 abundance in a murine model of diet-induced obesity. 
48 Glycomacropeptide (GMP) is a by-product of cheese making and it is released in whey 
49 protein from the kappa-casein fraction of milk by the activity of chymosin 20. 
50 Glycomacropeptide has five mucin-type glycans, high content of sialic acid, high content of 
51 branched chain amino acids (BCAA) and essential amino acids (EAA) and is deficient in of 
52 aromatic amino acids 20. Glycomacropeptide consumption is associated with a number of 
53 health benefits including anti-inflammatory and anti-GIT pathogen activity, and it is currently 
54 being used as an alternative source of protein for phenylketonuria (PKU) nutritional 
55 management 21, 22. 
56 There is inconclusive data on the prebiotic potential of GMP. Selective growth promotion of 
57 Bifidobacterium and Lactobacillus by GMP has been reported based on tests in pure cultures 
58 but the selectivity failed to be confirmed when complex faecal microbiota communities were 
59 tested in vitro 23-25. Some in vivo studies showed that GMP administration increased the 
60 colonic abundance of Lactobacillus and Bifidobacterium 26, 27. Sawin et al. 28 reported that a 
61 GMP-supplemented diet significantly decreased the caecal and colonic relative abundance of 
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562 Desulfovibrio and Proteobacteria in wild type and PKU mice. Interestingly, GMP selectivity 
63 for promoting growth of Bacteroidetes taxa has also been reported 27, 28. 
64 In this study, conventional mice were treated with a cocktail of antibiotics to deplete the gut 
65 microbiota before receiving faecal microbiota from either a healthy or a frail elderly donor. 
66 The effect of a diet supplemented with either lactose-free milk, whole milk, GMP or soy 
67 protein (control) on the transplanted faecal microbiota of elderly humans was then 
68 investigated in these “humanised” mice. 
69 Materials and Methods
70 Animals and experimental design
71 The Health Products Regulatory Authority (HPRA) of Ireland under the European Union 
72 Regulations authorised this project with authorisation number AE19130/P033. Nighty-six 6 
73 week-old female and male C57BL/6 mice were purchased from Envigo RMS Ltd, Oxon, UK 
74 and caged in groups of six of the same sex. The mice were weighed during the first week and 
75 every subsequent week of the trial.
76 The mice were acclimatised to the animal facility for one week before the commencement of 
77 the six weeks antibiotics (Abx) treatment for the depletion of the indigenous murine gut 
78 microbiota. Ampicillin (1g/L; Sigma Aldrich, St Louis, USA), Metronidazole (1g/L; 
79 Molekula, Darlington, UK ), Vancomycin (500 mg/L; Molekula, Darlington, UK ), Imipenem 
80 (250 mg/L; Molekula, Darlington, UK) and Ciprofloxacin-HCl (200 mg/L; Santa Cruz 
81 Biotechnology, Dallas, USA) were diluted in tap water and filter-sterilised before being given 
82 to animals as described before 29. Animals had ad libidum access to Abx-water. Limited 
83 administration of HydroGel (ClearH2O.com) during the Abx treatment was used for the 
84 prevention of weight loss. Animals that lost more than 35% of their body weight were 
85 euthanised. One-day wash-out with filtered tap-water followed the Abx treatment. 
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686 Subsequently, the animals were “humanised” for three days with faecal microbiota from 
87 either a healthy elderly donor (EM425) or a frail elderly donor (EM297). The mice were 
88 introduced to the experimental diets on the wash-out day; the mice were ca. 14 weeks-old at 
89 the beginning of the dietary intervention. The duration of the dietary intervention was one 
90 month. Faecal samples were taken on the first day of acclimatisation (baseline), throughout 
91 the Abx treatment (time points T1 and T2), one week after humanisation (T3), in the mid-part 
92 of the dietary intervention (T4) and at the end of the trial (T5) (Figure S1). 
93 Six male and 6 female mice were allocated to each diet (Table S1). The animals were fed 
94 maintenance diet (ssniff, Spezialdiäten GmbH, German) during the acclimatisation period 
95 and during the Abx treatment. The experimental diets (ssniff, Spezialdiäten GmbH, 
96 Germany) were supplemented with one of the following powders: i. lac-free diet: 20% 
97 lactose-free whole milk powder (Valio Ltd., Helsinki, Finland); ii. wmilk diet: 20% whole 
98 milk powder (Valio Ltd., Helsinki, Finland); iii. GMP diet: 20% CGMP-10 (Arla Food 
99 Ingredients, Denmark); iv. control diet: 20% soy protein isolate (provided by ssniff, 
100 Spezialdiäten GmbH, Germany). In order to achieve the isoenergetic and isonitrogenous 
101 profile of the test diets, all diets were additionally supplemented with soy protein isolate 
102 (Table 1) which was the basic protein ingredient for the maintenance diet. The complete 
103 compositional data content of the experimental diets is provided in Appendix A. All diets 
104 were sterilized by irradiation. The lactose-free milk powder (Valio Ltd., Helsinki, Finland) 
105 was produced from whole milk powder (Valio Ltd., Helsinki, Finland) by partial removal of 
106 lactose using filtration and by enzymatic hydrolysation of the remaining lactose to glucose 
107 and galactose.
108 Faecal slurry preparation and mouse “humanisation”
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7109 One faecal sample from a healthy 81 yr old (EM425; community “COM” type microbiota) 
110 and one from a frail 82 yr old subject (EM297; longstay “LS” type microbiota) were 
111 collected under the approval of the local Clinical Research Ethics Committee. The samples 
112 were processed under anaerobic conditions for the preparation of 10% w/v faecal slurries in 
113 PBS with 20% glycerol. The faecal slurries were kept in aliquots at -80°C and thawed in the 
114 anaerobic cabinet before gavage to mice. The animals received faecal slurry over three days 
115 by oral gavage from a total of 300 μl.
116 Faecal sample collection and genomic DNA extraction
117 Faecal samples were collected during the trial at various time points (T0 to T5) as indicated 
118 in Figure S1. One to two faecal pellets were collected at each time point and were 
119 immediately frozen in liquid nitrogen before being transferred to -80°C. Total DNA was 
120 extracted from murine faecal pellets and caecum content using the QIamp Fast DNA Stool 
121 (Qiagen, Manchester, UK) kit. Murine pellets were weighed before performing the extraction 
122 using the QIamp Fast DNA Stool (Qiagen, Manchester, UK) extraction kit protocol. The 
123 samples were placed in sterile tubes containing 0.1 mm, 0.5 mm and 1.0 mm zirconia/glass 
124 beads (Thistle Scientific, UK). Eight hundred ml of InhibitEX buffer was added to the 
125 samples and then homogenised under one pulse of 1 min and a final of 30 sec using a Mini-
126 Beadbeader (Biospec Products, USA). In the intervals of the homogenisation steps the 
127 samples were placed on ice for 1 min. The samples were then placed in a 95°C heat-block for 
128 5 min. The subsequent steps of the DNA extraction were carried out as described in the 
129 Qiagen protocol using 15 μl of proteinase K with 200 μl of AL buffer, 200 μl of lysate and 
130 200 μl of ethanol at the relevant steps. 
131 Library preparation for 16S rRNA gene amplicon sequencing
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8132 The V3/V4 variable region of the 16S rRNA gene was targeted for Illumina MiSeq System 
133 sequencing (San Diego, California, USA). The region was amplified using the universal 16S 
134 ribosomal RNA gene primer pair S-D-Bact-0341-b-S-17 (5’-CCTACGGGNGGCWGCAG-
135 3’) / S-D-Bact-0785-a-A-21 (5’GACTACHVGGGTATC TAATC C-3’) 5’ 30. The Phusion 
136 High-Fidelity PCR Master Mix (ThermoFisher Scientific, Waltham, MA, USA) was used for 
137 the amplification. The PCR products were purified and the subsequent library preparation 
138 steps were performed according to the Illumina MiSeq system protocol. Dual-index barcodes 
139 were attached to the amplicon (Nextera XT V.2 Index Kits sets A and D, Illumina) and then 
140 purified using the Agencourt AMPure XP-PCR Purification system (Beckman Coutler, Inc., 
141 California, USA). The indexed amplicons were quantified using the Qubit dsDNA HS Assay 
142 Kit (Thermo Fischer Scientific, MA, U.S.A.). The pooled library containing the same 
143 concentration of each amplicon was sequenced (2 x 250 bp) on a MiSeq Illumina platform in 
144 the Teagasc Food Research Centre sequencing facility (Fermoy, Ireland). 
145 Microbiota composition analysis
146 FLASH programme 31 was used to join the paired-end reads that were subsequently quality 
147 filtered in Qiime (v.1.9.1) using the split_libraries_fastq.py script 32. Forward primer was 
148 removed using cutadapt 33 and reverse primer with QIIME’s script 
149 truncate_reverse_primer.py. The USEARCH sequence analysis tool was used for further 
150 quality filtering and de novo operational taxonomic unit (OTU) clustering. The sequences 
151 were filtered by length, sorted by size and single unique sequences were removed. The 
152 remaining sequences were clustered into OTUs based on 97% identity. Subsequently, 
153 UCHIME with the GOLD reference database was used for chimera removal. The initial 
154 quality filtered sequences were mapped against the OTUs (97 % identity). OTU 
155 representative sequences were taxonomically classified (classify.seqs) from phylum down to 
156 genus level with a 80% confidence threshold by using the mothur suite of tools (v1.36.1 ) and 
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9157 the RDP database (trainset 14) [34]. SPINGO was used in order to classify the OTUs at 
158 species level 35. Alpha and beta diversity analysis was performed in QIIME on a rarefied 
159 OTU table at 1300 reads in order to include the majority of the samples collected throughout 
160 the study. The sequences were aligned using the PyNast tool 36 in Qiime in order to generate 
161 alpha (α) diversity indices i.e., Shannon, Simpson, PD whole tree, Chao1 and Observed 
162 Species, and beta (β) diversity indices i.e. Weighted UniFrac and Unweighted UniFrac. 
163 Statistical analysis
164 The statistical software R (3.2.5; R Core Team) was used for statistical analysis and 
165 visualisation of data. The reads per sample were converted into relative abundances and 
166 ggplot2 (v. 2.2.1) was used for the visualisation of the bacterial composition of the 
167 microbiota. Principal coordinates analysis (PCoA) was performed with Weighted and 
168 Unweighted UniFrac distances with the made4 package (v. 1.50.1). Analysis of similarities 
169 (ANOSIM) was used (vegan 2.4-3) for the detection of significant differences in the observed 
170 clustering between the groups. A Kruskal-Wallis test followed by a Dunn’s post hoc test 
171 (dunn.test 1.3.4) with Benjamini-Hochberg p value adjustment for multiple testing was 
172 applied in order to detect significant differences in the faecal microbiota diversity and taxa 
173 relative abundances due to diet at T4 and T5.Values were considered significant when 
174 Kruskal-Wallis p<0.5, Kruskal-Wallis padj <0.1 and Dunn’s post hoc test padj <0.1. 
175 Significance indications: “●”padj<0.1; “*” padj<0.05; “**” padj<0.01; “***” padj<0.001; “****” 
176 padj<0.0001. Graph Pad Prism (v 5.03) was used to visualise alpha diversity scores and 
177 animal body weight and to perform a Kruskal-Wallis test on body weight values at the end of 
178 the trial. 
179 Results and Discussion
180 Effects of treatment on animal body weight
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181 Due to initial aversion of the animals to the Abx water and subsequent abstinence from chow 
182 during the first 2 weeks of the Abx treatment, some animal body weight loss was observed 
183 (Figure S2) and 8 animals were euthanised. The animals begun to recover their body weight 
184 after the 2nd week of Abx treatment (Figure S2). At the end of the trial (T5), consumption of 
185 the milk supplemented diets resulted in increased body weight compared to baseline but not 
186 significantly different to the other diets effect (Figure S2). Upon dissection all animals had 
187 normal spleen weight (data not shown). The number of animals in each dietary group at T5 
188 for which the gut microbiota was analysed is shown in Table S1.
189 Characterisation of human donor microbiota and its engraftment in mice 
190 General features of the compositional and phylogenetic diversity differences between the 
191 faecal microbiota of frail long-term care unit-residing elderly subjects and healthy 
192 community-living were described in the ElderMet study 37. The ElderMet subjects EM297 
193 (LS) and EM425 (COM) were re-enrolled and their faecal microbiota was re-analysed in 
194 order to confirm suitability for the mouse trial. Compositional differences at taxon level 
195 between COM and LS type faecal microbiota have been described before 25. Compared to the 
196 COM type microbiota, the LS microbiota had lower Firmicutes relative abundance, and it 
197 was enriched in Proteobacteria, Synergistetes and Bacteroidetes (Figure 1), but as expected 
198 for a subject of this type, the alpha diversity was lower (Table S2). Thus, the inocula were 
199 considered suitable for proceeding with mouse humanisation. 
200 One week after humanisation (T3), the murine faecal microbiota had diverged from baseline 
201 and did not revert back to the original murine phylogenetic profile by the completion of the 
202 trial (T5), as demonstrated by analysis of the Weighted and Unweighted UniFrac distances at 
203 time-point 3 (T3; Figure S3) and T5 (Figure 2). Importantly, the COM or LS type 
204 phylogenetic separation in β-diversity was retained at T5 as shown by PCoA of the 
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205 Unweighted UniFrac distances (Figure 2B) in spite of the effect of diet that drove the 
206 abundance-based clustering (Figure 2A). The faecal microbiota from mice fed the wmilk and 
207 the lac-free diets clustered closer together compared to the mice fed the control or GMP diets 
208 irrespective of humanisation microbiota type (Figure 2A). A detailed description of the 
209 differential effect of the diet supplements on the faecal microbiota follows further below. 
210 Importantly, the murine host may have played a role in re-shaping the relative abundances of 
211 taxa in the xenomicrobiota (i.e. the human microbiota, LS or COM type). It has been reported 
212 that the gut of germ-free or antibiotic-treated mice may be refractory to Clostridium clusters 
213 XIVa and IV taxa colonisation but more susceptible to Bacteroidetes colonisation 38. The 
214 Bacteroidetes and especially Porphyromonadaceae enrichment across most dietary groups at 
215 T5 and the compositional profile of the Lachnospiraceae at T5 comprised of mostly two taxa 
216 groups i.e. unclassified Clostridium cluster XIVa and unclassified Lachnospiraceae (Figure 
217 S5), can be viewed as the result of selective pressure applied by the murine host to reshape 
218 the relative abundances of the shared with the human xenomicrobiota taxa to best fit murine 
219 host physiology and immunity 39, 40. Barnesiella intestinihominis and Parabacteroides 
220 goldsteinii were the most abundant Porphyromonadaceae taxa in the microbiota of COM type 
221 humanised mouse whereas Parabacteroides merdae was the most abundant 
222 Porphyromonadaceae in LS type humanised mouse (Figure S5).
223 The lactose-free milk supplemented diet sustained higher microbiota diversity
224 In mice colonised with either human microbiota type, the lac-free diet sustained significantly 
225 higher faecal microbiota diversity compared to the wmilk or GMP diets, performing as 
226 efficiently as the soy protein supplemented diet (control) (Figure 3A and B). For example, 
227 for COM type humanised mouse microbiota at T5, feeding with lac-free diet resulted in ca. 
228 4.5 Shannon diversity index which was significantly higher compared to the other three diets, 
229 whereas the effect of the lac-free diet feeding on indices PD (ca. 8) and Observed Species (ca. 
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230 90) was similar to that of the control diet (Figure 3A). A similar trend was observed for LS 
231 type humanised mouse microbiota; upon the lac-free diet the Shannon diversity index was ca. 
232 4.1, the PD was ca. 5.5 and the Observed Species index was 58 (Figure 3B). Some animal 
233 and human studies indicate the prebiotic potential of soy and its products 41. Decreased gut 
234 microbiota diversity is a biomarker of ageing and frailty, and dietary supplements 
235 contributing to sustaining diversity may slow down ageing-related health loss 37, 42. The 
236 efficiency of the lac-free milk diet in retaining microbiota diversity can be attributed partly to 
237 the BMOs available for microbiota fermentation. Bovine milk oligosaccharides have attracted 
238 interest as potential prebiotics due to their structural complexity and similarity to HMOs 43, 44. 
239 The effect of the diets on the diversity of the faecal microbiota of female and male mice 
240 analysed separately was similar to that presented here for the aggregated microbiota across 
241 gender (data not shown). The alpha diversity indices Chao 1 and Simpson were also analysed 
242 and indicated similar significant results as those presented in Figure 3 (data not shown).
243 Differential effect of dietary supplementation on microbiota composition
244 Diet had a significant effect on the composition of the murine faecal microbiota as shown in 
245 Figure 2. In order to profile the detailed effect of the diets on the faecal microbiota of mice at 
246 T5, PCoAs of the UniFrac distances for the faecal microbiota per humanisation microbiota 
247 type were generated, i.e. COM type humanisation (Figure 4 A and B) and LS type 
248 humanisation (Figure 4 C and D). The ANOSIM test result confirmed the significant effect 
249 of the diets on the β-diversity (Figures 4). Within the diet-based clustering, the mouse gender 
250 had a significant impact on further sub-clustering of the microbiota in most of the dietary 
251 groups (gender is denoted by shape in Figures 4). The ANOSIM test result showed that the 
252 effect of gender was significant (p<0.05) for most of the dietary groups and that the variation 
253 observed was due to the gender effect (R≈1) (Table 2). Gender did not have a significant 
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254 effect on the GMP and lac-free dietary groups for LS colonised mice (Weighted and 
255 Unweighted, respectively) (Table 2; Figure 4 C and D).
256 Prebiotic potential of the lactose-free milk 
257 The murine faecal microbiota (either colonisation type) was enriched in Ruminococcaceae 
258 upon receiving the lac-free diet (17% and 4.6% average relative abundance, COM and LS 
259 type colonisation, respectively) (Figure 5, S4). The responsiveness of the Ruminococcaceae 
260 in the female mice was comparable to control diet (p>0.1) (Figure 6A and 7A), whereas in 
261 the male mice the Ruminococcaceae responsiveness to the lac-free diet was either 
262 comparable to wmilk diet (p>0.1) (COM type colonisation: Figure 6B) or significantly 
263 higher compared to all diets (p<0.09) (LS type colonisation; Figure 7B). The 
264 Ruminococcaceae enrichment associated with the lac-free diet could indicate that such a 
265 dietary supplementation might contribute to colonic health and healthy ageing as suggested 
266 by previous studies for these taxa 45, 46. In the LS humanised mice the Ruminococcaceae 
267 reached high relative abundance after the lac-free diet but not as high as in COM type 
268 humanised mice, potentially due to low starting abundance of this family in the LS 
269 microbiota (Figures 5 and 7). In COM type colonised female mice and LS type colonised 
270 mice Flavonifractor plautii was a dominant Ruminococcaceae taxon whereas Anaerotruncus 
271 colihominis and Oscillibacter taxa were differentially abundant in female and male COM 
272 type colonised mice (Figures 8 and S5). Others have reported probiotic-associated 
273 Anaerotruncus enrichment of dysbiotic murine microbiota after Abx treatment 47 whereas 
274 Oscillibacter and Flavonifractor taxa have been associated with resistant starch degradation 
275 and identified in the gut microbiota of lean individuals 48, 49. However, caution is needed 
276 before extrapolating these findings to human dietary interventions because some studies 
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277 report enrichment of Oscillibacter in cancer associated microbiota and Anaerotruncus 
278 enrichment in the microbiota of frail elderly 50, 51.
279 Effect of the whole milk supplemented diet on the gut microbiota
280 The whole milk supplemented diet was less efficient than the lac-free diet in sustaining 
281 microbiota diversity based on the alpha diversity indices at T5 (Figure 3). For COM type 
282 humanised mouse microbiota, the wmilk diet resulted in ca. 4.1, 6.7 and 64 Shannon, PD and 
283 Observed Species indices, respectively, that were significantly lower compared to the 
284 respective indices upon the lac-free diet supplementation (Figure 3A). Similar results were 
285 observed for LS type colonised mouse microbiota (Figure 3B). However, the comparative 
286 increase in the relative abundance of certain taxa after the wmilk diet warrants further 
287 investigation. The Ruminococcaceae family were responsive to the wmilk diet only in the 
288 male mice (Figures 5, 6 and 7). Ruminococcus bromii (6% average relative abundance; 
289 detected only in the COM type colonised male mice) and other unclassified taxa were the 
290 dominant Ruminococcaceae representative taxa (Figures 8C and S5C). Ruminococcus 
291 bromii is a dominant gut microbiota taxon highly responsive to resistant starch, essential in 
292 nutrient degradation and as such it can be a prebiotic target leading to substrate release in the 
293 colon and increase in cross-feeding mediated by short chain fatty acids (SCFA) production 52, 
294 53. 
295 The significant effect of the wmilk diet on the relative abundance of the Erysipelotrichaceae 
296 (Firmicutes) is evident in Figure S4. In animals with COM type colonisation, the 
297 Erysipelotrichaceae were the most abundant Firmicutes family in the male mouse microbiota 
298 (23% average relative abundance) with Allobaculum as the most abundant representative 
299 taxon (22% average relative abundance) (not detected in the female mice) (Figure 8C), 
300 whereas Turicibacter was dominant in female mice (1.6% average relative abundance) (not 
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301 detected in male mice) (Figure 8B). In animals with LS type colonisation, low in abundance 
302 Erysipelotrichaceae taxa were significantly enriched in the male mouse microbiota upon 
303 wmilk diet feeding (0.6% average relative abundance) (Figure 7B). Allobaculum stercorianis 
304 was the dominant Erysipelotrichaceae taxon in the female mouse microbiota (32% average 
305 relative abundance) similarly to what was observed in the microbiota of COM type 
306 humanised male mice that were fed the wmilk diet (Figures 8B, S5B). The 
307 Erysipelotrichaceae enrichment of the faecal microbiota of the wmilk diet fed mice and the 
308 responsiveness of Allobaculum taxa to the whole milk supplementation may also be a 
309 positive effect on the microbiota. In murine trials, high-fat diet-associated dysbiosis and 
310 impaired gut barrier function were restored after BMO supplementation correlating to 
311 Allobaculum (and Ruminococcaceae) enrichment of the microbiota 19; 54. Inulin 
312 supplementation had similar effect on Allobaculum taxa associated with improved vascular 
313 function 55. However, experimental extrapolation to human diet is needed due to Allobaculum 
314 association with thrombosis risk through trimethylamine-N-oxide (TMAO) metabolism and 
315 to other erysipelotrichial associations with the obesity phenotype in murine models 54, 55. 
316 Interestingly, the wmilk diet, similarly to the lac-free diet, sustained the highest 
317 Lachnospiraceae relative abundance in the murine microbiota compared to the GMP and 
318 control diets. Analytically, COM type humanisation: ca. 12% and 15%, upon wmilk and lac-
319 free diet, respectively; LS type humanisation: ca. 15.5% and 29% upon wmilk and lac-free 
320 diet, respectively (Figures 5 and S4). Taxa belonging to unclassified Lachnospiraceae and 
321 unclassified Clostridium cluster XIVa were the representative Lachnospiraceae taxa (Figure 
322 8). 
323 Here the Acidaminococcaceae taxon Phascolarctobacterium faecium, an asaccharolytic 
324 bacterium, was responsive to the wmilk diet (5.6% average relative abundance in COM type 
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325 colonised mouse) and the GMP diet (5% and 6% average relative abundance in COM and LS 
326 type colonised mouse, respectively), and to a lesser extent to the control diet (1.8% and 1.1% 
327 average relative abundance in COM and LS type colonised mouse, respectively) (Figures 8 
328 and S5). We have previously reported Acidaminococcaceae responsiveness to GMP 
329 supplementation in an in vitro colon system 25. The Acidaminococcaceae family relative 
330 abundance was significantly increased upon wmilk diet mainly when compared to the control 
331 and lac-free diet in COM type humanised mice (Figures 6). In LS colonised mice, the 
332 relative abundance of the Acidaminococcaceae increased significantly upon GMP diet in the 
333 female mice (Figure 7A); the Acidaminococcaceae family was also abundant in the male 
334 mouse microbiota (Figure 5B and C; Figure S4B). In previous mouse model studies, the 
335 taxon Phascolarctobacterium was linked to soy diet-associated metabolic markers 
336 improvement 58, whereas Lecomte et al. reported that the taxon increased after high–fat diet 
337 59. Tran et al. 60 reported the positive association of the taxon to high fibre diet in both murine 
338 and human intervention studies. 
339 Desulfovibrionaceae responsiveness to the dairy diets
340 All three milk-associated diets presented in this study had some effect on the relative 
341 abundance of the Desulfovibrionaceae family of the Proteobacteria. In animals that received 
342 COM type colonisation, the GMP diet had the strongest effect on the Desulfovibrionaceae 
343 taxon Bilophila wadsworthia that reached 11.5% average relative abundance upon the GMP 
344 diet (Figure S5). The control and wmilk diet had the weakest effect on the 
345 Desulfovibrionaceae/Bilophila taxa responsiveness in the female (4% average relative 
346 abundance) and male mice (1.8% average relative abundance), respectively (Figures 6 and 
347 8). In LS type colonised mice, the taxon Bilophila was not detected and Desulfovibrio was 
348 the Desulfovibrionaceae representative, responsive to the lac-free diet, reaching an average 
349 8% relative abundance (Figures 5, 8). Contrary to what we report in the current study, Sawin 
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350 et al. 28 reported that over a month of 20% GMP supplemented diet resulted in reduced 
351 Desulfovibrionaceae/Desulfovibrio relative abundance and amelioration of inflammatory 
352 markers in wild type (WT) and phenylketonuria (PKU) C57Bl/6 mice and compared to casein 
353 and amino acids supplemented diets, respectively. 
354 Desulfovibrio spp. is a taxon negatively correlated to health in elderly people 50. Previous 
355 studies have reported that intake of milk-derived high-fat diet resulted in Bilophila 
356 wadsworthia associated dysbiosis and inflammation in mouse models 61, 62. Recently, 
357 Natividad et al 63 using a mouse model observed that milk fat promoted B. wadsworthia, 
358 inflammation and bile acid metabolism deregulation. Importantly, colonic health was 
359 promoted by reduced Bilophila relative abundances in human gut microbiota 64. Importantly, 
360 although some mouse model studies show that milk fat may be associated with negative 
361 health outcomes associated with increased Bilophila abundance, other studies support non-
362 deleterious effects of dairy fat on health 73, 74, 75. The balance of the potentially positive and 
363 negative effects of milk diets on the faecal microbiota needs to be measured and considered 
364 in human studies.
365 Bacteroidetes responsiveness to the dairy diets
366 Phylum Bacteroidetes encompasses many fibrolytic and saccharolytic taxa 68. The 
367 Bacteroidetes were more responsive to the dairy diets then to control. In COM type colonised 
368 mice, Bacteroidetes had ≥55% average relative abundance upon the dairy diets and 40% upon 
369 control diet, whereas for LS type colonised mice, the Bacteroidetes had ≥42% average 
370 relative abundance upon the dairy diets and 32% upon control diet (Figure 5). In the female 
371 mice with COM type humanisation, the families Porphyromonadaceae, Rikenellaceae and 
372 other unclassified Bacteroidales were highly responsive to the GMP diet (Figure 6A), 
373 whereas for either gender the Bacteroidaceae (mainly Bacteroides thetaiotaomicron and 
374 Bacteroides uniformis) were significantly increased upon the wmilk diet (Figure 6, S5B). 
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375 The Porphyromonadaceae responsiveness upon the GMP diet was high also in the male mice 
376 with COM type humanisation, whereas the Bacteroidaceae were least responsive to the GMP 
377 diet compared to the other diets (Figure 6B). In the LS type colonised mice, the families 
378 Bacteroidaceae, Porphyromonadaceae and Rikenellaceae were responsive to the dairy diets, 
379 whereas the Rikenellaceae were also highly responsive to the control diet (the latter response 
380 was also observed in the male animals with COM type humanisation) (Figures S4B, 6B). 
381 Increase in Bacteroides population due to GMP-supplementation has been reported in mouse 
382 model studies 27, 28. Milk and subsequently GMP contain highly sialylated carbohydrate 
383 components 10. Interestingly, different Bacteroidaceae taxa have been associated with 
384 sialidase activity with or without sialic acid utilisation ability 69, 70. In the current study, 
385 compared to the other diets, feeding with the GMP diet resulted in Enterobacteriaceae 
386 enrichment in the faecal microbiota of COM type colonised mice (4% average relative 
387 abundance) (Figures 5 and S4A); Escherichia/Shigella taxa were the dominant 
388 Enterobacteriaceae representatives (Figure 8). The sialic acid content of the GMP may have 
389 contributed to the reported comparative increase in Enterobacteriaceae relative abundance 69. 
390 Charbonneaeu et al. 71 reported growth improvement in a gnotobiotic mouse and piglet 
391 models through cross-feeding between Bacteroides taxa that could degrade sialic acid-
392 containing carbohydrates from sialylated BMO and secondary utilisers of sialic acid-
393 containing compounds like E.coli. Importantly, a similar response upon GMP diet was not 
394 observed in LS humanised mice; the Enterobacteriaceae were more responsive to the lac-free 
395 diet (1.7% average relative abundance) (Figures 5 and 8). These findings in combination to 
396 existing literature may highlight the need for caution when designing the dose for human 
397 trials using milk because the sialylated carbohydrate component may induce the growth of 
398 pathobionts of the E.coli/Shigella group 71.
399 Enrichment of the microbiota in Verrucomicrobiaceae in some dietary groups 
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400 Enrichment of the Verrucomicrobiaceae family (Akkermansia) (≥38% average relative 
401 abundance) was observed at T5 upon the control diet in the faecal microbiota of COM type 
402 humanised mouse and in LS type humanised mouse microbiota upon the GMP and control 
403 diets (Figures 5 and 8). The values of the Shannon alpha diversity index (that measure 
404 evenness 72) at T5 may have been biased due to the high relative abundance of Akkermansia 
405 (i.e. decreased alpha diversity values in the dietary groups where the Akkermansia bloom was 
406 observed) and for this reason the alpha diversity was analysed at an earlier time-point, i.e. in 
407 the middle of the dietary intervention (T4) (Figure S6) in order to confirm the effect of the 
408 lac-free diet on sustaining the microbiota diversity. The Verrucomicrobiaceae bloom was 
409 detected at T4 only for mice humanised with COM type microbiota but not in LS type 
410 humanised mice. For either colonisation type at T4, both milk supplemented diets (i.e. the 
411 lac-free and the wmilk diets) sustained significantly higher alpha diversity indices (Shannon, 
412 PD and Observed Species) compared to both GMP and control diet (Figure S7). The 
413 Akkermansia bloom could be attributed to the interruption of the Abx treatment due to 
414 HydroGel treatment in some dietary groups, to coprophagy and to cross-contamination 
415 between cages. Interestingly, Dubourg et al. 73 reported increased A. muciniphila colonisation 
416 in the gut microbiota of patients after broad-spectrum Abx treatment. 
417 Translatability to human nutrition
418 Milk is a widely accessible dietary product, it combines an array of valuable nutrients and 
419 many recent human cohort studies have demonstrated the health benefits of dairy 
420 consumption including milk 74-76. Importantly, BMOs may be an efficient prebiotic substrate 
421 similar to HMOs 43, 44. We have investigated the gut microbiota modulatory potential of 
422 (lactose-free and whole) milk in a murine model. A lactose-free milk supplemented diet was 
423 found a better prebiotic candidate compared to whole milk supplemented diet as it retained 
424 higher microbiota diversity. However, the whole milk diet affected the abundance of 
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425 significant health-relevant microbiota taxa. Importantly, in LS type colonised mice, the 
426 wmilk diet sustained a higher Firmicutes relative abundance compared to the Bacteroidetes 
427 relative abundance (Figure 5) which may indicate the potential of milk to improve the 
428 Firmicutes dominance over the Bacteroidetes in the microbiota of frail elderly 50. When 
429 translating the findings of the current study to humans, the fact that mice may not fully 
430 tolerate lactose 77, and that the lactose fermentation in wmilk diet fed mice may have 
431 prevented BMOs utilisation by the gut microbiota, must be taken into consideration. 
432 Importantly, we did not observe any adverse outcomes in mice consuming the wmilk diet 
433 such as diarrhoea or abstinence from eating; furthermore the stool consistency of mice fed the 
434 wmilk diet (by macroscopic observation before DNA extraction) was similar to that of mice 
435 receiving the other diets. Whether or not the two milk types, i.e., whole milk and lactose-free 
436 milk, have a differential effect on the gut microbiota of lactase persistent subjects remains to 
437 be clarified in a clinical trial. Interestingly, dairy companies employ different preparation 
438 techniques for the manufacture of lactose-free milk. Whole milk can either be filtered in 
439 order for lactose to be retained and the remaining lactose is hydrolysed enzymatically (e.g. 
440 Valio Ltd. product used here) or whole milk is enzymatically treated without prior filtering. 
441 The two methods may result in lactose-free milk with differing residual content of simple 
442 sugars that, upon consumption, may result in differential effect on the gut microbiota. Future 
443 in vivo studies can clarify the potential differential effect on the gut microbiota of the two 
444 preparations. Importantly, in this study, similarly to previous observations, we observed 
445 gender dependent differential responses to diet partly attributed to hormonal effects 78, 79. 
446 Addressing gender-dependant responsiveness of the faecal microbiota to diet in murine 
447 models could increase translatability of the findings to human nutrition. 
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734 FIGURE CAPTIONS
735 Figure 1 Composition of the human and murine baseline faecal microbiota at family level. 
736 Bacterial families that were present at >1% relative abundance are presented. Murine: 
737 aggregated faecal microbiota across all mice at baseline; COM: community type faecal 
738 microbiota; LS: longstay type faecal microbiota.
739 Figure 2 Principal coordinates analysis (PCoA) of the UniFrac distances at the end of the trial 
740 (T5). A. Weighted UniFrac distances; B. Unweighted UniFrac distances. Blue: murine 
741 baseline microbiota; green colour coding: community (COM) type faecal microbiota; red 
742 colour coding: longstay (LS) type faecal microbiota. The inocula of human faecal microbiota 
743 (donors) are denoted with “▲” and the relevant red and green colour..
744 Figure 3 Alpha diversity indices at the end of the trial (T5). A: community (COM) type 
745 colonisation; B: longstay (LS) type colonisation. LAC_FREE: lactose free milk 
746 supplemented diet; WMILK: whole milk supplemented diet; GMP: glycomacropeptide 
747 supplemented diet; CONTROL: soy protein diet. Asterisks next to alpha diversity indices 
748 denote the result of the Kruskal-Wallis comparison; markings above boxplots denote the 
749 Dunn’s post hoc result. Significant values: “●” padj<0.1; “*” padj<0.05; “**” padj<0.01; 
750 “***” padj<0.001; “****” padj<0.0001.
751 Figure 4 Principal coordinates analysis (PCoA) of the faecal microbiota of mice at the end of 
752 the trial (T5). Community type (COM) humanisation: A: Weighted UniFrac distances; B: 
753 Unweighted UniFrac distances. Longstay type (LS) humanisation: C: Weighted UniFrac 
754 distances; D: Unweighted UniFrac distances.LAC_FREE: lactose free milk supplemented 
755 diet; WMILK: whole milk supplemented diet; GMP: glycomacropeptide supplemented diet; 
756 CONTROL: soy protein diet.”●”: female mice microbiota; “▲”: male mice microbiota. The 
757 ANOSIM results of the diet effect are noted. 
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758 Figure 5 Faecal microbiota composition at family level at the end of the trial (T5). COM: 
759 community type colonisation; LS: longstay type colonisation. A. microbiota composition of 
760 female and male mouse aggregated; B. female mouse microbiota composition; C. male 
761 mouse microbiota composition. LAC_FREE: lactose free milk supplemented diet; WMILK: 
762 whole milk supplemented diet; GMP: glycomacropeptide supplemented diet; CONTROL: 
763 soy protein diet. Bacterial families that were present at >1% relative abundance are presented.  
764 Figure 6 Differentially abundant taxa at family level at the end of the trial (T5) for 
765 community (COM) type humanisation. A: female mouse microbiota; B: male mouse 
766 microbiota. Asterisks next to taxa denote the result of Kruskal-Wallis comparison; markings 
767 above boxplots denote the Dunn’s post hoc result. Significant values: “●” padj<0.1; “*” 
768 padj<0.05; “**”padj<0.01; “***” padj<0.001; “****” padj<0.0001. 
769 Figure 7 Figure Differentially abundant taxa at family level at the end of the trial (T5) for 
770 longstay (LS) type humanisation. A: female mouse microbiota; B: male mouse microbiota. 
771 Asterisks next to taxa denote the result of Kruskal-Wallis comparison; markings above 
772 boxplots denote the Dunn’s post hoc result. Significant values: “●” padj<0.1; “*” padj<0.05; 
773 “**” padj<0.01; “***” padj<0.001; “****” padj< 0.0001. 
774 Figure 8 Faecal microbiota composition at genus level at the end of the trial (T5). COM: 
775 community type colonisation; LS: longstay type colonisation. A. microbiota composition of 
776 female and male mouse aggregated; B. female mouse microbiota composition; C. male 
777 mouse microbiota composition. LAC_FREE: lactose free milk supplemented diet; WMILK: 
778 whole milk supplemented diet; GMP: glycomacropeptide supplemented diet; CONTROL: 
779 soy protein diet. Bacterial genera that were present at >1% relative abundance are presented. 
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780 Figure S 1 Timeline of the mouse trial. Time points of faecal sample collection: baseline (T0) 
781 during acclimatisation; T1 and T2 during the antibiotic treatment; T3, T4 and T5 during the 
782 dietary intervention. 
783 Figure S 2 Animal body weight during the 11 weeks of the trial. The body weight from the 
784 first week of Abx treatment (W0) till the completion of the trial (W11) is shown. Body 
785 weight change between baseline and end of trial (T5) is shown at the bottom. A and B: COM: 
786 community type humanisation; LS: longstay type humanisation, respectively.
787 Figure S 3 Principal coordinates analysis (PCoA) of the UniFrac distances one week after 
788 “humanisation” (T3). A: Weighted UniFrac distances; B: Unweighted UniFrac distances. 
789 Blue: murine baseline microbiota; green colour coding: community (COM) type faecal 
790 microbiota; red colour coding: longstay (LS) type faecal microbiota. Colour shading denotes 
791 the test diets. The inocula of human faecal microbiota are denoted with “▲” and the relevant 
792 red and green colour.
793 Figure S 4 Differentially abundant taxa at family level at the end of the trial (T5) for 
794 aggregated female and male mouse faecal microbiota. A: community (COM) type 
795 colonisation; B: longstay (LS) type colonisation. Asterisks next to taxa denote the result of 
796 Kruskal-Wallis comparison; markings above boxplots denote the Dunn’s post hoc result. 
797 Significant values: “●” padj<0.1; “*” padj<0.05; “**” padj<0.01; “***” padj<0.001; “****” 
798 padj<0.0001. COM type humanisation: Differences in the Erysipelotrichaceae relative 
799 abundance shown in Figures 6 and S4A are due to filtering for taxa presence in the compared 
800 groups for the statistical analysis. LS type humanisation: Due to filtering of the taxa tables for 
801 the statistical analysis, Allobaculum that was not detected in the LS type colonised male mice 
802 and fed wmilk diet (Figure 8C), was not represented in Figure 7.
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803 Figure S 5 Faecal microbiota composition at species level at the end of the trial (T5). COM: 
804 community type colonisation; LS: longstay type colonisation. A. microbiota composition of 
805 female and male mouse aggregated; B. female mouse microbiota composition; C. male 
806 mouse microbiota composition LAC_FREE: lactose free milk supplemented diet; WMILK: 
807 whole milk supplemented diet; GMP: glycomacropeptide supplemented diet; CONTROL: 
808 soy protein diet. Bacterial species present at >1% relative abundance are shown. Colour 
809 coding: purple: Bacteroidetes; green: Firmicutes; red: Proteobacteria; blue: Verrucomicrobia.
810 Figure S 6 Composition of the murine faecal microbiota at family level at the mid part of the 
811 dietary intervention (T4). COM: community type microbiota; LS: longstay type microbiota. 
812 LAC_FREE: lactose free milk diet; WMILK: whole milk diet, GMP: glycomacropeptide diet; 
813 CONTROL: soy protein diet. Only phyla present at >1% relative abundance are presented. 
814 Figure S 7 Alpha diversity indices at the mid part of the dietary intervention (T4). A: 
815 community (COM) type colonisation; B: longstay (LS) type colonisation. LAC_FREE: 
816 lactose free milk supplemented diet; WMILK: whole milk supplemented diet; GMP: 
817 glycomacropeptide supplemented diet; CONTROL: soy protein diet. Asterisks next to alpha 
818 diversity indices denote the result of the Kruskal-Wallis comparison; markings above 
819 boxplots denote the Dunn’s post hoc result: Significant values: “●” padj<0.1; “*” padj<0.05; 
820 “**” padj<0.01; “***” padj<0.001; “****” padj<0.0001.
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TABLES
Table 1 Composition of the customised experimental diets (ssniff Spezialdiäten GmbH).
Ingredient
%
Control 20% whole 
milk powder 
20% lactose-
free milk 
powder
20% CGMP-
10 powder
Soy protein isolate 20.0 14.5 12.75 1.8
Whole milk powder - 20.0 - -
Lactose-free milk 
powder
- - 20.0 -
Glycomacropeptide 
CGMP-10
- - - 20.0
Maltodextrin 33.1 33.2 32.85 32.0
Sucrose 10.5 2.5 4.3 10.3
Cellulose powder 6.0 4.9 5.0 5.2
Soybean oil 7.5 2.3 2.3 7.5
Contents %
Crude protein 18.1 18.1 18.1 18.1
Crude fat 7.6 7.6 7.6 7.6
Crude ash 4.6 5.4 5.6 5.5
Starch 31.8 31.9 31.6 30.8
Sugar (total) 12.3 12.3 12.3 12.3
Lactose - 8.0 - -
Energy (MJ/kg) 16.0 16.0 16.0 16.0
kcal % Protein 19 19 19 19
kcal % Fat 18 18 18 18
kcal % Carbohydrates 63 63 63 63
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Table 2 ANOSIM test results for the effect of gender on the observed PCoA clustering of the 
faecal microbiota at the end of the trial (T5).
COM LS
Weighted Unweighted Weighted Unweighted
                                                              ANOSIM
p value R p value R p value R p value R
Control 0.005 0.98 0.006 1.0 0.004 0.75 0.003 1.0
GMP 0.014 0.98 0.01 0.94 0.41 0.0 0.005 1.0
Lactose-
free milk 0.009 1.0 0.008 1.0 0.04 0.37 0.19 0.10
Whole 
milk diet 0.008 1.0 0.005 1.0 0.028 1.0 0.035 1.0
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Supporting Information
Table S 1 Treatment groups indicating the diet, gender and the colonisation with human 
faecal microbiota type. The number of animals in each dietary group at T5 for which the gut 
microbiota was analysed is shown. The experimental arms of groups A, B, C and D were 
performed simultaneously followed by the experimental arms of groups E, F, G and H. The 
animals that received HydroGel treatment during Abx period, is indicated by #.
 
Community type human 
microbiota (COM)
Longstay type human microbiota 
(LS)
 female male female male
Lactose free 
milk
A (n=5) A (n=5) B (n=4) B (n=5)
Whole milk C (n=6) C (n=4) D (n=4) D (n=4)
GMP E (n=5)# E (n=4)# G (n=6) G (n=6)
Control H (n=6)### H (n=6) F (n=6)## F (n=5)###
 “#”,“##”,“###” three, six and nine days, respectively of HydroGel intake
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Table S 2 Alpha diversity indices of the faecal microbiotas of the human donors and the 
murine baseline faecal microbiota. EM297: longstay type faecal microbiota (LS); EM425: 
community type faecal microbiota (COM); murine: aggregated faecal microbiota across all 
mice at baseline. 
Alpha Diversity Index MURINE EM297 LS
EM425 
COM
Shannon 6.0 4.0 6.0
Simpson 1.0 1.0 1.0
PD Whole tree 15.0 9.0 17.0
Observed species 207.0 73.0 169.0
Chao 1 346.0 104.0 264.0
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